Chemical Compounds
Vorapaxar
67%
Autophagy Inhibitor
62%
Fibrin Degradation Product
55%
EC 1.17.3.2 (Xanthine Oxidase) Inhibitor
51%
Proton Pump Inhibitor
50%
Erythropoietin
46%
Chemical Transformation
41%
Drug Target
37%
Coagulation
33%
Lactate
33%
Antagonist
30%
Glutathione
29%
Disorder
28%
Nanocomposite
21%
Peptide
18%
Ligand
14%
Protein
13%
Molecule
11%
Medicine & Life Sciences
Oral Submucous Fibrosis
100%
Wounds and Injuries
31%
Patents
31%
tiplaxtinin
26%
vorapaxar
22%
Lactate Dehydrogenase 5
19%
Fibrosis
19%
Fibrin Fibrinogen Degradation Products
18%
Nanocomposites
17%
Xanthine Oxidase
16%
Chromium
15%
Manuscripts
15%
Proton Pump Inhibitors
14%
Antibodies
14%
Long Noncoding RNA
14%
Erythropoietin
13%
Fibronectins
12%
Autophagy
12%
Cell- and Tissue-Based Therapy
12%
Chemokines
12%
Glutathione
11%
Iron
10%
Interleukin-6
10%
Stem Cells
9%
Ligands
9%
Neoplasms
8%
Peptides
8%
Cytokines
8%
Inflammation
7%
Therapeutics
6%
Incidence
6%
Pharmaceutical Preparations
5%
Proteins
4%